Matches in Wikidata for { <http://www.wikidata.org/entity/Q95315177> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q95315177 description "article scientifique publié en 2020" @default.
- Q95315177 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q95315177 description "scientific article published on 18 May 2020" @default.
- Q95315177 description "wetenschappelijk artikel" @default.
- Q95315177 description "наукова стаття, опублікована 18 травня 2020" @default.
- Q95315177 description "գիտական հոդված հրատարակված 2020 թվականի մայիսի 18-ին" @default.
- Q95315177 name "Important interactions of immunosuppressants with experimental therapies for novel coronavirus disease (COVID-19): how to act" @default.
- Q95315177 name "Important interactions of immunosuppressants with experimental therapies for novel coronavirus disease (COVID-19): how to act" @default.
- Q95315177 type Item @default.
- Q95315177 label "Important interactions of immunosuppressants with experimental therapies for novel coronavirus disease (COVID-19): how to act" @default.
- Q95315177 label "Important interactions of immunosuppressants with experimental therapies for novel coronavirus disease (COVID-19): how to act" @default.
- Q95315177 prefLabel "Important interactions of immunosuppressants with experimental therapies for novel coronavirus disease (COVID-19): how to act" @default.
- Q95315177 prefLabel "Important interactions of immunosuppressants with experimental therapies for novel coronavirus disease (COVID-19): how to act" @default.
- Q95315177 P1433 Q95315177-60E5C8B3-6C95-45A0-B97D-C11129BBE289 @default.
- Q95315177 P1476 Q95315177-BCF417B6-0814-4CA7-9E11-0B33C7CE2FB7 @default.
- Q95315177 P2093 Q95315177-30576523-3C11-4F34-81B6-634FFDC6F465 @default.
- Q95315177 P2093 Q95315177-6A056966-7A6D-4D76-A4EF-2597580E45B7 @default.
- Q95315177 P2093 Q95315177-88880D62-5F4B-42F9-AAE7-3D0576AB0562 @default.
- Q95315177 P2093 Q95315177-99076F60-688E-49E4-B740-7B15FFB529CA @default.
- Q95315177 P2093 Q95315177-E9284F4F-8095-4345-96BB-7290EBBEA403 @default.
- Q95315177 P2093 Q95315177-F0834F08-0A5B-445A-8EBB-79C45A6D52C6 @default.
- Q95315177 P31 Q95315177-0279BBD0-0C18-43CA-87BC-4429640A883D @default.
- Q95315177 P356 Q95315177-BEC0122E-32C4-4E72-85EC-0E40510A62B3 @default.
- Q95315177 P577 Q95315177-2AE1C00F-1CFE-40BC-A0F8-081872DF03E8 @default.
- Q95315177 P698 Q95315177-23BAB765-1056-4A56-8861-4B121DEC8BEC @default.
- Q95315177 P8150 Q95315177-03431c49-3a88-4d34-a357-38f9a501230f @default.
- Q95315177 P8299 Q95315177-4B7CF0E2-85AE-4317-B1D2-F7A52654D2DA @default.
- Q95315177 P921 Q95315177-FFC12E07-4104-4ADA-9AF3-BB4E6225B094 @default.
- Q95315177 P356 FTD.0000000000000766 @default.
- Q95315177 P698 32433189 @default.
- Q95315177 P1433 Q15724567 @default.
- Q95315177 P1476 "Important interactions of immunosuppressants with experimental therapies for novel coronavirus disease (COVID-19): how to act" @default.
- Q95315177 P2093 "Daan J Touw" @default.
- Q95315177 P2093 "Jos G W Kosterink" @default.
- Q95315177 P2093 "Martha L Toren-Wielema" @default.
- Q95315177 P2093 "Prashant V Nannan Panday" @default.
- Q95315177 P2093 "Stefan P Berger" @default.
- Q95315177 P2093 "Tanja R Zijp" @default.
- Q95315177 P31 Q13442814 @default.
- Q95315177 P356 "10.1097/FTD.0000000000000766" @default.
- Q95315177 P577 "2020-05-18T00:00:00Z" @default.
- Q95315177 P698 "32433189" @default.
- Q95315177 P8150 "covidwho-324844" @default.
- Q95315177 P8299 "218765294" @default.
- Q95315177 P921 Q84263196 @default.